SCHEMBL9642148

SCHEMBL9642148

O=C1C(Cl)=C(Cl)C(=O)c2cc(Cc3ccccc3)ccc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 1/20 0.52
▸ DNMT1 P26358 1/20 0.52
▸ DNMT3L Q9UJW3 1/20 0.52
▸ DNMT3A Q9Y6K1 1/20 0.52
▸ PARP11 Q9NR21 1/20 0.49
▸ MAPK1 P28482 3/20 0.49
▸ NPC1 O15118 2/20 0.49
▸ LMNA P02545 2/20 0.49
▸ MAPT P10636 2/20 0.49
▸ RAB9A P51151 2/20 0.49
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ ALDH1A1 P00352 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ NSD2 O96028 2/20 0.44
▸ HSP90AA1 P07900 2/20 0.44
▸ HKDC1 Q2TB90 2/20 0.44
▸ TLR9 Q9NR96 2/20 0.44
▸ G6PD P11413 1/20 0.44
▸ CCR6 P51684 1/20 0.44
▸ PGR P06401 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6762077 0.89 MAPK1 (0.60) PARP11MAPK1NPC1LMNAMAPT
SCHEMBL21811333 0.87 MAPK1 (0.63) PARP11MAPK1NPC1LMNAMAPT
SCHEMBL10883168 0.85 MAPK1 (0.61) PARP11MAPK1NPC1LMNAMAPT
SCHEMBL16265473 0.85 LMNA (0.55) PARP11MAPK1NPC1LMNAMAPT
SCHEMBL21840832 0.81 NPC1 (0.56) PARP11MAPK1NPC1LMNAMAPT
SCHEMBL9627609 0.80 PTPN1 (0.45) PARP11MAPK1NPC1LMNAMAPT
SCHEMBL9644120 0.79 ALDH1A1 (0.55) PARP11MAPK1NPC1LMNAMAPT
SCHEMBL10525358 0.77 PARP11 (0.44) PARP11MAPK1NPC1LMNAMAPT
4,4'-Methylenedianiline SCHEMBL9370050 0.76 IDO1 (0.59) IDO1DNMT1DNMT3LDNMT3AMAPK1
SCHEMBL889584 0.74 ALOX15 (0.48) PARP11LMNAALDH1A1IDH1CALM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0215622-B1 NAPHTHALENE ANTI-PSORIATIC AGENTS AND PROCESS FOR MAKING THEM SYNTEX (U.S.A.) INC. (US) 1992-06-17 — — EP disclosed
US-4946845-A STABLE ANTIINFLAMMATORY AGENTS, LIPOXYGENASE INHIBITORS SYNTEX (U.S.A.) INC. (US) 1990-08-07 — — US disclosed
EP-0146145-B1 NAPHTHALENE ANTI-PSORIATIC AGENTS SYNTEX (U.S.A.) INC. (US) 1989-08-30 — — EP disclosed
US-4792556-A LIPOXYGENASE INHIBITORS SYNTEX (U.S.A.) INC. (US) 1988-12-20 — — US disclosed
EP-0215622-A2 Naphthalene anti-psoriatic agents and process for making them SYNTEX (U.S.A.) INC. (US) 1987-03-25 — — EP disclosed
US-4593120-A Naphthalene-1,4-dicarboxylic acid group SYNTEX (U.S.A.) INC. (US) 1986-06-03 — — US disclosed
EP-0107512-B1 1,4-ACYLOXYNAPHTHALENE DERIVATIVES, TOPICAL COMPOSITIONS CONTAINING THEM, METHODS FOR THEIR PREPARATION, AND INTERMEDIATES THEREFOR SYNTEX (U.S.A.) INC. (US) 1986-02-26 — — EP disclosed
EP-0146145-A2 Naphthalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1985-06-26 — — EP disclosed
US-4466981-A Naphthalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1984-08-21 — — US disclosed
EP-0107512-A1 1,4-Acyloxynaphthalene derivatives, topical compositions containing them, methods for their preparation, and intermediates therefor SYNTEX (U.S.A.) INC. (US) 1984-05-02 — — EP disclosed
Send feedback